EGFR and squamous cell carcinoma: Compared to A549 cells treated with serum-derived exosomes from ADK WT, squamous cell carcinoma, and healthy donors, A549 cells treated with exosomes from patients with an EGFR mutation showed a significant increase of vimentin and a slight decrease of E-cadherin, canonical markers of EMT [21] (Figure 3D,E).